ApoE Mimetic Peptide Reduces Plasma Lipid Hydroperoxide Content with a Concomitant Increase in HDL Paraoxonase Activity -- Interrelationships Between Paraoxonase-1 and Monocyte Chemoattractant Protein-1 in the Regulation of Hepatic Inflammation -- Biomarkers of Sensitivity and Exposure in Washington State Pesticide Handlers -- Paraoxonase 1 Status as a Risk Factor for Disease or Exposure -- Engineering Human PON1 in an E. coli Expression System -- The Toxicity of Mixtures of Specific Organophosphate Compounds is Modulated by Paraoxonase 1 Status -- Identification and Characterization of Biomarkers of Organophosphorus Exposures in Humans -- Temporal and Tissue-Specific Patterns of Pon3 Expression in Mouse: In situ Hybridization Analysis -- PON1 and Oxidative Stress in Human Sepsis and an Animal Model of Sepsis -- Paraoxonase 1 Attenuates Human Plaque Atherogenicity: Relevance to the Enzyme Lactonase Activity -- The Role of Paraoxonase 1 in the Detoxification of Homocysteine Thiolactone -- Alteration of PON1 Activity in Adult and Childhood Obesity and Its Relation to Adipokine Levels -- Anti-Inflammatory Properties of Paraoxonase-1 in Atherosclerosis -- Paraoxonase 1 Interactions with HDL, Antioxidants and Macrophages Regulate Atherogenesis – A Protective Role for HDL Phospholipids -- The Effect of HDL Mimetic Peptide 4F on PON1 -- The Contribution of High Density Lipoprotein Apolipoproteins and Derivatives to Serum Paraoxonase-1 Activity and Function -- Paraoxonase 1, Quorum Sensing, and P. aeruginosa Infection: A Novel Model.

*** This series does not include back cover copy. ***